Psychiatry Tomorrow
Psychiatry Tomorrow
Osmind
Psychiatry is entering a new era. Join host Carlene MacMillan, M.D., Psychiatrist and Chief Medical Officer at Osmind, for Psychiatry Tomorrow, where we delve into captivating conversations with mental health leaders advancing the field. From groundbreaking research and technology, to the modern private practice and the policies shaping psychiatry’s future. Navigate the exciting realms of neuromodulation, rapid-acting antidepressants, metabolic psychiatry, psychedelic medicine, starting a private practice, and much more. Join us on this thrilling journey, and let’s transform mental health together.
TMS Works. Almost Nobody Gets It. Scott West, MD on Closing the Gap
Dr. Scott West brought TMS to Tennessee in 2010. Why do so few patients get TMS for treatment-resistant depression, and how can clinicians close the gap?
Jun 4
37 min
A Spravato Patient's Story: From 10 Failed Antidepressants to Marathons and Horror Novels
Hear how one Spravato patient went from cycling through 10 antidepressants to building a life he loves — running marathons, writing novels, and surfing. Ben Leopold shares how the combination of deep therapeutic work and Spravato treatment finally broke through his treatment-resistant depression.
Feb 26
50 min
Why Sleep Is Psychiatry's Blind Spot—And How to Fix It with Avinesh Bhar, MD
Sleep disorders hide behind psychiatric diagnoses. Drs. Avinesh Bhar, Will Sauvé, and Brittany Albright discuss how sleep apnea mimics TRD, anxiety, and ADHD—and what clinicians can do about it.
Jan 21
48 min
Vagal Nerve Stimulation for Depression with Lucian Manu, MD
Vagal nerve stimulation (VNS) treats treatment-resistant depression with unique benefits: effects improve over 12-24 months, low relapse rates, and reduces ketamine frequency. Learn patient selection criteria, Medicare RECOVER trial access at 80+ sites, insurance appeals process, and how VNS creates a clinical "floor" preventing deepest episodes. Expert insights from Dr. Lucian Manu, Stony Brook University.
Nov 5, 2025
46 min
Should a Psychiatrist Ever Prescribe a GLP-1? with Brittany Albright, MD, MPH
GLP-1 receptors throughout the brain's reward pathway make these medications psychiatric tools for treating depression and other mental health issues, not just metabolic issues. Learn evidence-based patient selection criteria for treating cravings, compulsivity, and metabolic dysfunction in psychiatric practice with Will Sauvé, MD, and Brittany. Albright, MD, MPH.
Oct 23, 2025
48 min
How TMS is Rewiring Psychiatry with Martha Koo, MD
Dr. Martha Koo bought her first TMS machine in 2009 when colleagues thought she was "crazy," and now runs 11 centers as immediate past president of the Clinical TMS Society. Her insights reveal why TMS doesn't require patient belief, how early billing accidentally funded research, and where neuromodulation is headed with accelerated protocols and implantable devices.
Sep 17, 2025
53 min
Lifestyle Psychiatry: How Creatine + Exercise Rewires Depressed Brains with Dr. Nicholas Fabiano
New research shows exercise (especially when paired with creatine) can match antidepressants for treating mild-to-moderate depression by triggering muscle proteins that act like "miracle grow for the brain." Dr. Nicholas Fabiano explains how psychiatrists are using systematic exercise protocols and creatine supplementation alongside traditional treatments, plus warning signs when exercise becomes harmful. Learn the FIT framework for prescribing exercise and why the future of mental health care means treating mind and body as one system.
Jun 4, 2025
47 min
From Crisis to Community: Transforming High-Risk Psychiatric Care Beyond Hospital Walls with Matthew Bernstein, M.D.
After eight years at McLean Hospital's acute unit, Dr. Matt Bernstein chose to treat high-risk psychiatric patients in their communities rather than behind hospital walls. Through his work at Ellenhorn and the innovative Accord Metabolic Psychiatry Program, he demonstrates how combining measurement-based care, metabolic approaches, and meaningful social connection can transform outcomes for complex cases—challenging traditional assumptions about risk and recovery in psychiatry.
Feb 20, 2025
56 min
The SPRAVATO® Story with Dr. Hussesini K. Manji,
Dr. Husseini K. Manji reveals the groundbreaking journey of esketamine (SPRAVATO®) from lab to FDA approval. Discover how this rapid-acting antidepressant is reshaping depression treatment and paving the way for future psychedelic medicines.
Oct 24, 2024
23 min
How to Build a Breakthrough Treatment Clinic with Charles Miller, CRNA
Charles Miller, CRNA, shares his journey of building Scenic City Neurotherapy from a small startup to a thriving ketamine and TMS clinic. He offers practical advice on patient education, navigating insurance, and overcoming business challenges, providing invaluable insights for clinicians looking to start or expand their own breakthrough treatment practices.
Sep 26, 2024
48 min
Load more